BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19239324)

  • 21. Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina.
    Pérez LO; Abba MC; Dulout FN; Golijow CD
    World J Gastroenterol; 2006 Mar; 12(9):1426-9. PubMed ID: 16552814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 codon 72 polymorphism and rheumatoid arthritis.
    Lee YH; Kim YR; Ji JD; Sohn J; Song GG
    J Rheumatol; 2001 Nov; 28(11):2392-4. PubMed ID: 11708408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility.
    To-Figueras J; Gene M; Gomez-Catalan J; Galan C; Firvida J; Fuentes M; Rodamilans M; Huguet E; Estape J; Corbella J
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):337-42. PubMed ID: 9162298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study.
    Shen H; Zheng Y; Sturgis EM; Spitz MR; Wei Q
    Cancer Lett; 2002 Sep; 183(2):123-30. PubMed ID: 12065086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TP53 Codon 72 Polymorphism and the Risk of Colorectal Cancer in an Azerbaijani Population.
    Yagublu V; Bayramov B; Yuce M; Aslanov H
    Turk J Gastroenterol; 2022 Jun; 33(6):485-490. PubMed ID: 35786616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 codon 72 polymorphism and the risk of esophageal cancer: a Korean case-control study.
    Piao JM; Kim HN; Song HR; Kweon SS; Choi JS; Yoon JY; Chung IJ; Kim SH; Shin MH
    Dis Esophagus; 2011 Nov; 24(8):596-600. PubMed ID: 21595775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 codon 72 polymorphism in basal cell carcinoma of the skin.
    Pezeshki A; Sari-Aslani F; Ghaderi A; Doroudchi M
    Pathol Oncol Res; 2006; 12(1):29-33. PubMed ID: 16554913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TP53 codon 72 polymorphism and colorectal cancer susceptibility: a meta-analysis.
    Wang JJ; Zheng Y; Sun L; Wang L; Yu PB; Dong JH; Zhang L; Xu J; Shi W; Ren YC
    Mol Biol Rep; 2011 Nov; 38(8):4847-53. PubMed ID: 21140221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P53 codon 72 and HER2 codon 655 polymorphisms in Turkish breast cancer patients.
    Kara N; Karakus N; Ulusoy AN; Ozaslan C; Gungor B; Bagci H
    DNA Cell Biol; 2010 Jul; 29(7):387-92. PubMed ID: 20380571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of the TP53 codon 72 polymorphism with colorectal cancer in a Chinese population.
    Zhu ZZ; Wang AZ; Jia HR; Jin XX; He XL; Hou LF; Zhu G
    Jpn J Clin Oncol; 2007 May; 37(5):385-90. PubMed ID: 17599946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Association of TP53 gene polymorphisms with genetic susceptibility to liver metastases of colorectal cancer].
    Wang AZ; Zhu ZZ; Cong WM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):168-71. PubMed ID: 18393238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of p53 Codon 72 Polymorphism with Breast Cancer in a Rwandese Population.
    Habyarimana T; Attaleb M; Mugenzi P; Mazarati JB; Bakri Y; El Mzibri M
    Pathobiology; 2018; 85(3):186-191. PubMed ID: 29131100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of TP53 codon 72 and CDH1 genetic polymorphisms with colorectal cancer risk in Bangladeshi population.
    Rivu SF; Apu MNH; Shabnaz S; Nahid NA; Islam MR; Al-Mamun MMA; Nahar Z; Rabbi SNI; Ahmed MU; Islam MS; Hasnat A
    Cancer Epidemiol; 2017 Aug; 49():46-52. PubMed ID: 28554075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The p53 codon 72 polymorphism and lung cancer risk.
    Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.
    Langerød A; Bukholm IR; Bregård A; Lønning PE; Andersen TI; Rognum TO; Meling GI; Lothe RA; Børresen-Dale AL
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1684-8. PubMed ID: 12496062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India.
    Ihsan R; Devi TR; Yadav DS; Mishra AK; Sharma J; Zomawia E; Verma Y; Phukan R; Mahanta J; Kataki AC; Kapur S; Saxena S
    DNA Cell Biol; 2011 Mar; 30(3):163-71. PubMed ID: 21043833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of TP53 gene codon 72 polymorphism with endometriosis in Mexican women.
    Gallegos-Arreola MP; Figuera-Villanueva LE; Puebla-Pérez AM; Montoya-Fuentes H; Suarez-Rincon AE; Zúñiga-González GM
    Genet Mol Res; 2012 May; 11(2):1401-8. PubMed ID: 22653586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
    Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP
    Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 codon 72 polymorphism and the risk of lung cancer in a Korean population.
    Piao JM; Kim HN; Song HR; Kweon SS; Choi JS; Yun WJ; Kim YC; Oh IJ; Kim KS; Shin MH
    Lung Cancer; 2011 Sep; 73(3):264-7. PubMed ID: 21316118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
    Ignaszak-Szczepaniak M; Horst-Sikorska W; Sawicka J; Kaczmarek M; Slomski R
    Oncol Rep; 2006 Jul; 16(1):65-71. PubMed ID: 16786124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.